Correcting Misinformation in Social Media - Webinar CD/Transcript

$287.00
Quantity Discounts
1 - 2
$287.00
3 - 4
$258.00
5 - 6
$244.00
7 - 9
$230.00
10 - 9999
$215.00

Correcting Misinformation in Social Media: When, Where, Why and How To Do It

It’s happened again. A social media post. And it’s inaccurate. And someone — a customer perhaps — is sure to believe it.

What can you do — other than grind your teeth in frustration?

Should you correct it or ignore it?

How can you determine whether the positive benefits of social media outweigh the downsides?

In this 90-minute, nuts-and-bolts presentation by recognized social media expert Bradley Merrill Thompson, Member, Epstein, Becker & Green, and leader of the mHealth Regulatory Coalition, you’ll hear real-world examples about these all too real scenarios, and learn:

  • How to craft a social media policy that you can really rely on, even in How to craft a social media policy that you can really rely on, even in critical situations
  • How to get out in front of situations that call for proactive use of social media — without incurring additional legal liability
  • How a leading pharmaceutical company dealt with the posting of incorrect information about the side effects of one of its drugs
  • How medical device companies should respond to advertisements by law firms that recruit patients by attacking your products
  • How to deploy FDA guidance to establish a social media policy that is responsible and compliant
  • How to respond positively on Twitter and Facebook to customer complaints to squelch unfounded rumors and enhance your product online

Order today and learn how to craft your social media policy.

  • Auditors
  • Compliance officers
  • Consultants/service providers
  • Data management and statistics personnel
  • Executive management
  • General/corporate counsel
  • Investigators
  • Managers
  • Manufacturing directors and supervisors
  • Personnel new to the industry
  • Pharmaceutical and cGMP auditors
  • Regulatory/legislative affairs professionals
  • Risk management specialists
  • Strategic planning and business development staff

Bradley Merrill Thompson, Member, Epstein, Becker & Green
Bradley Merrill Thompson counsels medical device, drug, and combination product companies on a wide range of FDA regulatory, reimbursement and clinical trial issues.  Mr. Thompson regularly defends companies receiving FDA warning letters, on a wide gamut of subjects including good manufacturing practice, compliance and off label promotion.